1 min to read News Posted on February 8, 2023 Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary – Marketscreener.com Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary Marketscreener.com Source: Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary – Marketscreener.com share tweet share Tags: SPACs